MedPath

A clinical trial to study the effects of two drugs Tila-Dhatri kshara along with Gokshura kashaya and Potassium Magnesium Citrate B6 in patients with Kidney stones.

Phase 3
Not yet recruiting
Conditions
Calculus of kidney and ureter. Ayurveda Condition: MOOTRASHMARI,
Registration Number
CTRI/2020/11/029011
Lead Sponsor
CCRAS
Brief Summary

This study is a Non-randomized Active controlled trial to be conducted in 70 patients of Urolithiasis coming to the OPD of Sir Sunderlal Hospital ,IMS,BHU, Varanasi, Uttar Pradesh, India. The study is aimed at comparing the efficacy of ayurvedic drug with an allopathic drug. The 70 patients will be consecutively allocated in 2 groups of 35 patients each. One group will be given Tila-Dhatri kshara capsules 500mg along with Gokshura kashaya 48ml twice daily morning and evening before food for 45 days. The second group will be given Potassium Magnesium Citrate-B6 1500mg tablet twice daily morning and evening after food for 45 days. The primary outcome is lithotriptic activity which will be assessed by STONE score got through Non-Contrast CT scan on 0th and 46th day of drug administration. The SFR( Stone Free Rates ) is inversely proportional to the STONE score. The secondary outcome is subjective like Pain, Haematuria and Burning micturition. It will be assessed on 0th, 15th, 30th and 45th day of drug administration.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients presenting with signs and symptoms of Urolithiasis confirmed radiologically.(stone size < 10mm) 2.
  • Patients in the age group 18 – 70 yrs.
  • Patients of either sex.
  • Patients with informed consent.
Exclusion Criteria
  • Stag horn renal calculi 2.
  • Pyelonephritis 3.
  • Uncontrolled diabetes mellitus 4.
  • Malignancy 5.
  • Chronic renal failure 6.
  • Severe UTI 7.
  • Calculus associated with complications 8.
  • Calculi > 10mm 9.
  • Bladder stones 10.
  • Any other systemic symptoms like hyperparathyroidism, gout etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Lithotriptic activity using S.T.O.N.E score assessed via NCCT Scan0th day and 46th day
Obstruction0th day and 46th day
Number of stones0th day and 46th day
Evaluation of Hounsfield units0th day and 46th day
Size0th day and 46th day
Topography0th day and 46th day
Secondary Outcome Measures
NameTimeMethod
Pain using Wong-Baker Faces pain scaleHaematuria

Trial Locations

Locations (1)

Ayurveda wing, Sir Sunderlal Hospital

🇮🇳

Varanasi, UTTAR PRADESH, India

Ayurveda wing, Sir Sunderlal Hospital
🇮🇳Varanasi, UTTAR PRADESH, India
Dr Neethu Vijai
Principal investigator
9496077201
neeethurajeeev@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.